Health|May 20, 2026|1 min read

Health News: Leadership Vacuum at NIH and Broader HHS

The National Institutes of Health and broader Department of Health and Human Services face significant leadership challenges and organizational uncertainty.

#nih#hhs#leadership#health-policy#government

STAT News

Contributor

Unable to process: No markdown content was provided. Please supply the article body text to clean and process.

Share this story

Eli Lilly Reports Phase 1 Trial Data for VERV-102 Gene Editing Therapy Targeting Cholesterol

Eli Lilly has released Phase 1 trial data for VERV-102, a gene editing therapeutic designed to reduce cholesterol levels by targeting specific genetic pathways. The preliminary results represent a significant step forward in developing gene-based treatments for cardiovascular disease.